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Abstract
Background: T cell development occurs within the highly specialized thymus. Cytotoxic CD8 T cells are critical in
adaptive immunity by targeting virally infected or tumor cells. In this study, we addressed whether functional CD8
T cells can be generated fully in vitro using human umbilical cord blood (UCB) hematopoietic stem cells (HSCs) in
coculture with OP9-DL1 cells.




neg and thus phenotypically resembled mature functional CD8 single positive thymocytes. These in vitro-
generated T cells also appeared to be conventional CD8 cells, as they expressed high levels of Eomes and low
levels of Plzf, albeit not identical to ex vivo UCB CD8 T cells. Consistent with the phenotypic and molecular
characterization, upon TCR-stimulation, in vitro-generated CD8 T cells proliferated, expressed activation markers
(MHC-II, CD25, CD38), secreted IFN-g and expressed Granzyme B, a cytotoxic T-cell effector molecule.
Conclusion: Taken together, the ability to direct human hematopoietic stem cell or T-progenitor cells towards a
mature functional phenotype raises the possibility of establishing cell-based treatments for T-immunodeficiencies
by rapidly restoring CD8 effector function, thereby mitigating the risks associated with opportunistic infections.
Background
T lymphocytes develop within the thymus, undergoing
distinct differentiation events based on phenotype, while
following spatial-temporal cues. The most immature
human thymocytes are triple negative for CD3, CD4 and
CD8, but express CD34. CD7 is one of the earliest mar-
kers to be expressed during human T cell ontogeny, fol-
lowed by the upregulation of CD1a, which marks T cell
commitment. Following this stage, human thymocytes
progress to a CD4 immature single positive (CD4ISP)
stage, at which point CD4 is expressed in the absence of
CD8. Thereafter, a subset of CD4ISP cells are thought
to complete TCRb rearrangement leading to b-selection
and differentiation to the CD4
+ CD8
+ double positive
(DP) stage. Finally, following successful TCRa rearran-
gement, TCRab expressing DP thymocytes undergo
positive and negative selection events, which result





single positive (SP) T cells, which then emigrate to the
periphery [1].
Cytotoxic CD8 SP T cells play a critical role in adap-
tive immunity by destroying virally infected or malig-
nant cells. Cytoablative regimens to treat malignancies
or HIV infection results in the destruction of T cells,
leading to a period of immunodeficiency and a concomi-
tant increase in opportunistic infections [2]. While
hematopoietic stem cell (HSC) transplants can reconsti-
tute the entire immune system, T cells are the slowest
population to recover or may never recover at all [3,4].
The robust differentiation of multiple sources of HSCs
[5-9] into T-progenitors using the OP9-DL1 coculture
system suggests that these progenitor cells could be har-
vested in vitro to rapidly restore the T cell compartment
in vivo and thereby reduce the incidence of opportunis-
tic infection and ultimately improve therapeutic out-
comes [10]. While we have demonstrated that specific
populations of T-progenitor cells generated in vitro can
reconstitute the thymus of immunodeficient mice and
generate CD8 single positive (SP) T cells in vivo [8], it
was not clear whether functional maturation of mature
CD8 T cells could take place entirely in vitro starting
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cocultures.
Mature CD8 T cells were recently reported to be gen-
erated following coculture of early thymocyte progeni-
tors (ETPs) on OP9-DL1 monolayers [11]. The absence
o fac l i n i c a l l yv i a b l es o u r c ef r o mw h i c ht oi s o l a t el o w
frequency ETPs, makes it difficult to envision a thera-
peutic approach to treat T-immunodeficiency based on
harvested postnatal thymocytes (PNT). Therefore, it is
important to determine whether accessible sources of
HSCs, such as umbilical cord blood, directed to differ-
entiate in vitro can generate functionally mature CD8
T cells. Two elegant studies have reported the genera-
tion of cytotoxic human T cells from HSCs genetically
modified to express tumor-specific TCRs cocultured
with OP9-DL1 stromal cells [12,13]. Whether in vitro-
generated CD8 T cells derived from unmanipulated
HSCs could also give rise to mature functional T cells
and respond to signals delivered through an endogen-
ously generated TCR remained to be tested. Here we
demonstrate that long-term coculture of non-transduced
human UCB HSCs on OP9-DL1 cells generates ab-
TCR/CD3
+ CD8
+ SP T cells that exhibit the molecular
and cellular signatures corresponding to functionally
mature T cells.
Results
Phenotypic characterization of human CD8 SP T-cells
derived from HSCs cultured with OP9-DL1 cells
We have previously reported the ability to generate CD4
+ CD8
+ T-lineage cells as well as CD4 and CD8 single
positive (SP) cells from human cord blood-derived
CD34
+ CD38
-/low HSC/OP9-DL1 cocultures [7], how-
ever the maturational, molecular and functional status
of these CD8 SP T-cells were not assessed.
To address this, we analyzed long-term cocultures that
were allowed to differentiate for an extended period of
time. Figure 1 shows the presence of both DP and SP
subsets from a day 65 coculture. Examination of multi-
ple cocultures demonstrated the generation of CD8 SP
T cells (5.3% ± 1.2% (mean ± SE, n = 6)) after 60-70
days of culture. Additionally, Table 1 displays an analy-
sis for the number of CD8 T cells obtained from indivi-
dual OP9-DL1 cultures initiated with different numbers
of HSCs, which provides an indication of the expected
CD8 SP cell yields per input HSC. We further examined
the CD8 SP subset present in these cultures for the
expression of cell surface markers CD3 and CD27
[14,15], typically expressed on mature T-cells. Amongst
the SP CD8 cells (SP8s) found in late cocultures, about
50-60% (Figures 1 for 50% and Figures 3a for 60%)
expressed CD3/abTCR. Of note, the majority (57% ±
10%, n = 3) of CD3
+ SP8s were found to co-express
CD27. In addition, CD27
+ CD3
+ CD8
+ SPs were also
f o u n dt ol a c kC D 1 ae x p r e s s i o n ,w h i c hi si n d i c a t i v eo f




+ SPs that continued to express
CD1a, which is characteristic of the preceding stage in
T-cell differentiation [16] and consistent with reports
showing that the acquisition of functional maturity by
CD3
+ thymocytes following positive selection is asso-
ciated with the expression of CD27 and down-regulation
of CD1a expression [15,16].
Molecular analysis of in vitro derived human CD8 SP
T-cells from UCB HSCs
To gain further insight into the phenotypically charac-
terized CD8 SP T cells derived in vitro,w ee x a m i n e d
the expression of genes known to influence the differen-
tiation or effector status of CD8 T cells by quantitative
Figure 1 Characterization of CD8
+ T cells generated in vitro. Flow cytometric analysis for the expression of CD8 and CD4 from human UCB-
derived HSCs cultured on OP9-DL1 cells for 65 days. CD8
+ CD4
- single positive (SP) cells were gated, as indicated, and analyzed for the
expression of CD27 and CD3, with CD1a expression shown for cells gated as CD3
+ CD27
- or CD27
+ (shaded and clear histograms, respectively).
Data are representative of over 6 experiments for CD8/CD4 expression and of 3 experiments for CD27/CD1a expression.
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Page 2 of 9real-time PCR. We examined the expression of Th-POK
(Zbtb7b), Eomes, PLZF (Zbtb16) and Gata-3 transcript
levels in SP8 T cells obtained from CD34
+ CD38
-/low










+ SP8) T cells and CD33
+ myeloid cells
obtained from the mature lineage-positive fraction of
UCB were used as controls. Consistent with the role of
the zinc finger transcription factor Th-POK in CD4 line-
age-commitment [17], Th-POK transcripts were barely
detectable in coculture-derived SP8 T cells compared to
Lin
+ SP4 T cells (Figure 2). Also, a low, but detectable,
level of Th-POK expression was observed in UCB-ex
vivo Lin
+ SP8 T cells. In contrast, the T-box transcrip-
tion factor Eomes, which is a critical regulator for CD8
T cell differentiation and effector function [18], was
highly expressed in coculture-derived SP8 T cells at
levels that were lower but comparable to that of periph-
eral SP8 T cells obtained from Lin
+ UCB. Interestingly,
we also observed a high level of this transcription factor
in UCB-derived CD4 T cells, which is consistent with a
recent report showing the expression of Eomes in a sub-
set of naïve peripheral CD4 T cells [19]. In addition, the
N K Tc e l l / i n n a t eTc e l lt r a n s cription factor PLZF [20]
was expressed at low levels in HSC/OP9-DL1 coculture-
derived CD8 T cells similar to UCB CD8 peripheral
T cells. Lastly, we observed high levels of Gata-3
transcripts in coculture-derived SP8 T cells, likely owing
to the Delta-like-induced signaling of Notch in these
cells.
Generation of functional human CD8 T cells from HSCs
cultured with OP9-DL1 cells
To address the functional status of in vitro-generated
SP8s, we sorted the CD3/TCR-expressing subset (Figure
3A) and examined whether these cells had the capacity
to up/down-regulate downstream differentiation mar-
kers, proliferate, express cytolytic effector-function
molecules, and secrete g-interferon (IFNg) following
stimulation with immobilized anti-CD3/anti-CD28
mAbs for 5 days. As shown in Figure 3B, a blast-like
appearance based on Forward-light Scatter (FSC) is seen
in stimulated (Stim) cells as compared to non-stimulated
(NS) cells, which displayed significantly different (p=
0.004) FSC mean values when analyzed over multiple
experiments (NS, 460 ± 12; Stim, 524 ± 10). Additionally,
stimulated cells up-regulated CD45RO, CD38 and MHC-
class II expression, and down-regulated CD27 expression,
as compared to non-stimulated cells (Figure 3C). As
shown in Figure 3D, a similar trend was observed when
UCB ex vivo CD8 T cells were assayed. However, a more
prominent upregulation of CD45RO and CD38, and less
prominent downregulation of CD27, was observed. Never-
theless, further analysis of CD45RO MFI and the percen-
tage of CD27 expression (Figure 3E) demonstrated a
significant difference between non-stimulated and stimu-
lated in vitro-derived CD8 T cells. Indeed, this was also
observed for UCB-ex vivo CD8 T cells (Figure 3F).
Furthermore, to address the extent of cellular prolif-
eration induced by TCR-stimulation, sorted CD3
+ CD8
+
T-cells were loaded with CFSE and incubated for 5 days
with or without TCR-stimulation. Figure 4A shows that
stimulated cells undergo many rounds of cell division as
indicated by the loss of CFSE (left side) compared to
non-stimulated cells and by the increase in cellularity
(lower right-side). A similar loss of CFSE and increased
cellularity was observed in UCB-ex vivo T cells (Figure
4B, left-side and lower right-side). Like UCB-ex vivo
CD8 T cells, we observed that in vitro-derived prolifer-
ating cells also displayed marked up-regulation of CD25
expression (Figure 4A and 4B, left side). The average
percentage of CD25 on the cell surface of stimulated
cells was 78% ± 5%, which was significantly higher than
on non-stimulated cells (Figure 4A, upper right-side).
To determine whether these TCR-responsive in vitro-
derived CD8 SP T-lineage cells can be induced to
express cytotoxic/effector-function molecules, the
expression of Granzyme-B and IFNg were assessed.
Intracellular Granzyme-B expression was detected in
approximately 38% of stimulated CD3
+CD8
+ T-cells, as
compared to non-stimulated cells that expressed much
lower levels of Granzyme-B (Figure 4C). As demon-
strated in Figure 4D, when in vitro-derived CD8 T cells
were gated on Granzyme-B
+ cells, these corresponded
to CD25
+ proliferating cells. Finally, supernatants from
wells containing in vitro-generated CD8 SPs were ana-
lyzed for the presence of IFNg following stimulation. As
shown in Figure 4E, supernatants from cells stimulated
with either 2 μg/mL or 10 μg/mL of anti-CD3/anti-
CD28 mAbs showed a significant increase in the
amount of IFNg, as compared to non-stimulated cells.
In a separate set of experiments (Figure 4F), in vitro-
derived and UCB-ex vivo CD8 T cells were directly
compared, and showed similar levels of IFNg production
Table 1 Generation of TCR/CD3
+ CD8
+ cells from CD34
+
CD38
















a Indicates the number of TCR/CD3
+ CD8
+ T cells obtained after flow
cytometric sort purification from day 60-70 cocultures, which were seeded
with the indicated number of CD34
+ CD38
-/low cells.
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Page 3 of 9after TCR/CD28 stimulation. Taken together, these
results show that in vitro-derived CD8 SP T cells are
functionally mature.
Lastly, we also noted the appearance of CD3
+ CD4
+
T-cells (Figure 1A and 3A), which could be selected by
human MHC class II-expressing cells, which may be a
T-lineage cell or a non T-lineage cell such as a dendritic
cell. Indeed, when late day cultures were analyzed for




+ progenitor T cells and MHC-II
+ CD7
-
non-T-lineage cells were detected as shown in Figure
5A. Figure 5B, demonstrates the generation of CD33
+
CD7
- myeloid cells, which could provide MHC-II mole-
cules to developing T cells. Interestingly, in contrast to
the CD8 SPs, in vitro-generated CD4 SP T cells do not
show the hallmarks of being functionally mature T-cells.
Experiments examining their proliferative ability
revealed a lack of responsiveness to CD3 stimulation
(data not shown). Also confirming these findings was
the lack of CD27 expression on CD4 SP T-lineage cells
compared to CD8 T cells in the same culture (Figure 6).
Since this molecule is upregulated upon positive selec-
tion and present on mature naive T cells, the CD4 SP
generated in these cultures may represent transitional
cells that require additional differentiation signals that
are not readily available in these cultures.
Discussion
The HSC/OP9-DL1 cocultures not only serve to charac-
terize progenitor function or early events in human
T-cell development [8], but may also provide a simple
method for the generation of functional human T-cells
in vitro. This approach may be applicable to cell-based
immunotherapies that presently capitalize on T-cell
effector-function to induce/enhance anti-tumor eradicat-
ing immunity [21]. Thus far, adoptive cell transfer
(ACT) for tumor eradication has employed the use of
autologous and allogeneic T cells obtained from blood
or tumor-infiltrating lymphocytes, followed by expansion
protocols to generate millions of cells, with the efficacy
of ACT depending on the ability to generate large cell
numbers of T cells that maintain effector function. One
caveat to stromal-based cultures of HSCs into CD8
T cells is that clinically relevant numbers of CD8
+
T cells are not readily obtained (Table 1) following one
round of TCR-stimulation. However, one could attempt
to overcome this by promoting expansion of CD8
T cells with artificial-APCs and cytokines with several
rounds of stimulation [22,23]. Additionally, the number
of CD8 T cells obtained in these cultures is directly
related to the number of input HSCs; thus, expansion of
HSCs prior to differentiation into CD8
+ T cells would
provide another strategy for the large-scale generation
Figure 2 Gene expression analysis of CD8
+ SP T cells obtained from HSCs cultured on OP9-DL1 cells. Gene expression analysis by QRT-
PCR from coculture-derived CD8 SP T cells (CD8
+ CD4
- CD3
+). CD8 SP, CD4 SP T cells and CD33
+ myeloid cells were purified from the Lin
+
fraction of UCB samples and served as controls. Transcript levels for the indicated genes were normalized to human b-actin, and these data are
representative of 3 independent experiments, with the standard error bars shown corresponding to values obtained from triplicate wells within
an individual experiment.
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provide clear evidence for the maturation of functionally
responsive CD8 T cells generated from human UCB
HSCs in coculture with OP9-DL1 cells.
Although some of the gene transcript levels were not
identical to UCB-ex vivo CD8 T cells, this may be
reflect the fact that coculture-derived T cells are more
akin to human post-natal thymocytes, rather than
T cells found within the periphery. In addition, some
differences in cell surface expression may be due to dif-
ferent temporal kinetics of up/downregulation between
in vitro-generated versus UCB-ex vivo CD8 T cells.
Recently, van Coppernolle et al. reported the develop-
ment of CD8 SP abT cells and large numbers of gδT
cells following OP9-DL1 coculture from PNT. While
gδT cells can be detected in UCB-derived OP9-DL1
cocultures, we find them at very low frequencies (data
not shown). This suggests that the CD34
+ PNT, com-
pared to UCB HSCs, have received instructive signals
that are Notch independent, which appear to affect
specific T-lineage outcomes.
The observation that functionally mature CD8 SP T-
lineage cells are generated from HSCs on OP9-DL1
stroma, raises the question of which cell-type, within the
cultures, is mediating the MHC-dependent positive
selection of this population. It is unlikely that the OP9
cells, which express mouse MHC class I, which is not
effectively recognized by human CD8 molecules [26],
would supply the required positive selection signals.
Rather, a human MHC class I-expressing UCB-derived
cell, which may or may not be a T-lineage cell, is likely
to be the conveyor of these signals. Although van Cop-
pernolle et al. describe the generation of mature CD8 T
cells from postnatal thymocytes cocultured on OP9-
DL1, and excluded mouse MHC-I as a mode of selec-
tion due to its absence on OP9-DL1 cells, our analysis
showed that OP9-DL1 cells are in fact MHC class I-
expressing cells (data not shown), suggesting that this
possibility remains available for supporting CD8 positive
selection. Indeed, the high transcript levels of Eomes,
while low for PLZF, suggest that the in vitro-derived
CD8 SP cells are likely conventional T-lineage cells and
Figure 3 Characterization of activation marker status on activated CD8
+ T cells generated in vitro. (A) Day 60-70 HSC/OP9-DL1 coculture-
derived CD8 SP T cells were purified as shown, CD8
+ CD4
- and CD3
+, and stimulated anti-CD3/CD28 mAbs for 5 days. (B) Left-side panel
displays flow cytometric analyses of cell size measured by Forward-light Scatter (FSC) intensity; right-side panel displays mean FSC for non-
stimulated (NS) and stimulated (Stim) CD8
+ CD3
+ cells (n = 5; p = 0.004; t-test). (C) Flow cytometric analyses for the expression of CD45RO,
CD27, CD38 and MHC-class II for stimulated (Stim) and non-stimulated (NS) CD8
+ CD3
+ cells (solid black line and shaded histograms,
respectively). (D) Flow cytometric analyses for the expression of CD45RO, CD27, CD38 and MHC-class II for stimulated (Stim) and non-stimulated
(NS) CD8
+ CD3
+ cells obtained from the UCB Lin
+ fraction. Analysis of CD45RO mean fluorescence intensity (MFI) and percentage of CD27
+ cells
for (E) HSC/OP9-DL1 coculture (in-vitro)-derived CD8
+ CD3
+ T cells and (F) UCB-ex vivo CD8
+ CD3
+ T cells were performed (MFI CD45RO in vitro-
derived, p = 0.02; n = 3; t-test; %CD27
+ in vitro-derived, p = 0.007; n = 3; t-test; %CD27
+ UCB-ex vivo, p = 0.03; n = 2; t-test). * indicates statistical
significance.
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are typically the product of T-to-T selection [27], such
as NKT cells, gδ-T cells and innate CD8 T cells [28].
Conclusions
Taken together, our findings demonstrate that HSC/




-,a n df o l l o w i n gT C R - s t i -
mulation up-regulate CD25, CD45RO, CD38 and MHC
class II, while down-regulating CD27 expression. This
complex phenotype is unique to activated human
T cells [29,30] and consistent with full effector matura-
tion and effective cytolytic capability [31,32], as seen
with the induced expression of Granzyme-B and IFNg
Figure 4 Functional characterization on activated CD8
+ T cells generated in vitro. (A) Day 60-70 HSC/OP9-DL1 coculture-derived CD8 SP T
cells and (B) UCB-ex vivo CD8 T cells were purified and stimulated with anti-CD3/CD28 mAbs for 5 days. Flow cytometric analyses of CFSE levels
and CD25 (left side), and percentage of CD25
+ cells (upper right) and cellularity (lower right) for stimulated (Stim) versus non-stimulated (NS) are
shown (* indicates p < 0.05). (C) Analysis of the percentage of in vitro-derived CD8
+ CD3
+ intracellular Granzyme-B
+ expressing cells for
stimulated versus non-stimulated is shown (p = 0.02). (E-F) Human IFNg levels from culture supernatants derived from the above-outlined
experiment were determined by ELISA. (E) Statistical significance was measured by unpaired t-test for stimulated and non-stimulated in vitro-
derived T cells. * (p < 0.005) 2 μg/mL anti-CD3/CD28 stimulated group versus non-stimulated. ** (p < 0.0005) 10 μg/mL anti-CD3/CD28 versus
non-stimulated. Data are representative of at least 3 independent experiments, with the exception of the data from the 10 μg/ml stimulations,
which are derived from 2 independent experiments. (F) Statistical significance was measured by unpaired t-test for stimulated (10 μg/mL) and
non-stimulated UCB-ex vivo T cells. * (p < 0.05). Data are representative of at least 4 independent UCB-ex vivo CD8 T cells. The data from the in
vitro-generated T cells (non-stimulated and 10 μg/mL stimulation), are derived from 2 independent experiments.
Figure 5 Characterization of MHC class II-expressing cells derived from OP9-DL1 culture. Flow cytometric analysis for cell surface
expression of (A) MHC class II, CD7 (left side) and CD34 on MHC II
+ CD7
+-gated cells (solid black line) and MHC II
+ CD7
--gated cells (shaded
histogram) from a day 40 HSC/OP9-DL1 coculture, and (B) CD33 and CD7 from a day 45 HSC/OP9-DL1 coculture. Numbers in plots indicate
percentage of cells within each gate shown. Data are representative of at least 2 independent experiments.
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functionally responsive T cells derived in vitro from
HSCs may broaden the therapeutic avenue for treatment
of immunodeficiency and adoptive immunotherapy.
Methods
Umbilical cord blood samples
Human umbilical cord blood (UCB) samples were
obtained as previously described [8]. Briefly, within
24 hours of collection, cord blood mononuclear cells
were isolated using Ficoll density centrifugation and
then pre-enriched into lineage (Lin: CD2, CD3, CD14,
CD16, CD19, CD24, CD56, CD66b, glycophorin A)-
negative (Lin
-) and lineage-positive (Lin
+) fractions with
the autoMACS-pro cells sorter (Miltenyi Biotec,
Auburn, CA) using the StemSep
® human progenitor cell
enrichment cocktail (Stem Cell technologies, Vancouver,
BC, Canada). To isolate the human HSCs, Lin
- cells
were stained with anti-human CD38-APC and anti-
human CD34-FITC mAbs and sorted for CD34
+ CD38
-/
lo cells utilizing a FACSAria cell sorter (BD Biosciences,
San Jose, CA). Sorted human HSCs were greater than
99% pure as determined by post-sort analysis.
Human HSC and OP9-DL1 cell coculture
OP9-control or OP9-DL1 cells were generated and
maintained in OP9-media as previously described [5].
Typically, 1-5 × 10
4 sorted UCB HSCs (CD34
+ CD38
-/lo)
were added per individual well of a 6-well plate contain-
ing confluent OP9-DL1 cells, and the cultures were
maintained as previously described [33].
Flow Cytometry
Fluorescein isothiocyanate (FITC)-, R-Phycoerythrin
(PE)-, allophycocyanin (APC)-, PE-Cy7-, Alexa Fluor-
700 and eFluor 650NC antibodies were purchased com-
mercially (BD Biosciences, San Jose, CA or eBioscience,
San Diego, CA). FITC: anti-CD34, anti-HLA-DR/DP/
DQ (MHC-II), anti-CD3, anti-CD8; PE: anti-CD27, anti-
CD4, anti-CD7, anti-Granzyme B; APC: anti-CD1a, anti-
CD25, anti-CD38, anti-CD34; PE-Cy7: anti-CD8; Alexa
Fluor-700: anti-CD4; eFluor 650NC: anti-CD3, anti-
CD45RO. Intracellular staining for Granzyme B was per-
formed using the Cytofix/Cytoperm kit according to
manufacturer’s instructions (BD-Biosciences). Cell sus-
pensions were FcRII-blocked and stained, and analyzed
with a FACSCalibur (BD-Biosciences) or an LSR-II cyt-
ometer. Data analysis was performed using FlowJo soft-
ware (Tree Star, Ashland, OR) by gating on live
lymphocytes and lack of propidium iodide uptake. Num-





+ T cells or in vitro-
generated CD3/TCR-ab
+CD8
+ SP cells sorted from
HSC/OP9-DL1 cocultures at days 60-70, and 4 × 10
4
cells were seeded in individual wells of a flat bottom 96-
well plate coated with or without anti-CD3 [Clone
UCHT1] (2 or 10 μg/mL) and soluble anti-CD28 [Clone
CD28.2] (1 μg/mL) mAbs. All wells contained OP9-
media supplemented with rhIL-2 (1 ng/mL) and rhIL-7
(1 ng/mL) (Peprotech, Rocky Hill, NJ or R&D Systems,
Minneapolis, MN) cytokines and were analyzed after




+ T-cells were sorted and loaded
with 10 μM carboxyfluorescein succinimidyl ester
(CFSE) according to manufacturer’s protocol (Molecular
Probes, Eugene, OR) prior to plating. Loss of CFSE
labeling was assayed after 5 days of stimulation using a
FACSCalibur cytometer or an LSRII cytometer.
Quantitative real-time reverse-transcriptase polymerase
chain reaction (QRT-PCR)
Total RNA was isolated in Trizol-reagent and reverse
transcribed using Superscript-III and Oligo(dT)12-18 pri-
mers (Invitrogen, Burlington, ON). Diluted cDNA sam-
ples from sorted coculture-derived CD8
+ a n df r o mt h e
UCB Lin







+ T cells and CD33
+ cells were
used as templates for QRT-PCR reactions. Detection of
the QRT-PCR was performed with the SYBR Green
PCR master mix according to manufacturer’si n s t r u c -
tions (Qiagen, Mississauga, ON or Bio-Rad, Hercules
Figure 6 Characterization of single-positive T cells generated
from HSC/OP9-DL1 coculture. Flow cytometric analysis for cell
surface expression of CD4 and CD8 is presented for 2 independent
cocultures (left side). CD27 expression was examined on CD4
+ CD8
--




Awong et al. BMC Immunology 2011, 12:22
http://www.biomedcentral.com/1471-2172/12/22
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System 7000 (Life Technologies, Carlsbad, CA). All
transcript levels were normalized to human b-actin.
Gene-specific forward (F) and reverse (R) primers are as
follows: PLZF,( F )AGTGAGTGCAACCGCACCTT and
(R) GGAAGCAGCTGCCACAGAAC; Eomes, (F) ATG-
CAGGGCAACAAAATGTATG and (R) GTCTCATC-
CAGTGGGAACCAGTA; Th-Pok, (F) GCCTGGACA
GCCAAGACAAG and (R) AAGGGCTTCTCGCCTG
TGT; Gata-3, (F) GATGGCACGGGACACTACCT and
(R) GCTCTCCTGGCTGCAGACA;
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